Introduction
============

The human cerebellum has been long recognized as playing an essential role in motor control and coordination and it has also become increasingly aligned with cognitive and affective processing ([@B30]; [@B8]). Functional neuroimaging and connectivity studies in healthy humans suggest a topographic organization in the cerebellum: sensorimotor functions are represented in anterior lobules I--V and inferior lobule VIII, while cognitive processing is supported by posterior lobules ([@B33]). Cerebellar abnormalities have been found not only in primary cerebellar injury or degeneration, but also in many psychiatric and neurological diseases without ataxia, including Amyotrophic Lateral Sclerosis (ALS) ([@B20]; [@B10]).

ALS is a fatal multisystemic neurodegenerative disorder mainly characterized by progressive loss of upper and lower motor neurons with cognitive and/or behavioral disturbance in at least half of cases. ALS-associated cognitive syndrome includes impairment of executive function, often with perseveration, distractibility or inattention, language deficit and social cognition impairment ([@B34]). Personality change might also occur with apathy, blunting of affect or disinhibited and inappropriate behavior ([@B34]). In a subset (15%) of patients these cognitive and neuropsychiatric changes are severe enough to fulfill criteria for the behavioral variant of frontotemporal dementia (bvFTD) ([@B26]). ALS patients with the C9orf72 hexanucleotide repeat expansion (C9+ALS) had significantly more co-morbid bvFTD features than those without ([@B9]). Cognitive and neuropsychiatric features of ALS have largely been attributed to changes in the frontotemporal and insular cortex ([@B37]; [@B1]; [@B38]; [@B14],[@B15]; [@B11]), although increasing evidence suggest hippocampus and subcortical region degeneration also plays a role ([@B4]; [@B22]; [@B38]), especially in C9+ALS patients ([@B3]; [@B2]; [@B18]; [@B19]).

Evidence of cerebellar involvement in ALS is less commonly reported ([@B27]). Structural changes of the cerebellum in ALS have been described as regional white matter changes ([@B5]) and decrease gray matter volume ([@B36]; [@B20]; [@B11],[@B12]). Cerebellar changes in ALS and FTD have been specifically linked to the C9orf72 repeat expansion ([@B23]), raising the question whether cerebellar degeneration is an important feature of C9+ALS.

In order to explore the relationship between cerebellar involvement, cognitive impairment and C9orf72 repeated expansion of patients with ALS, quantitative *in vivo* assessment of cerebellar lobules has been investigated in a large sample of non-demented ALS patients stratified on the basis of cognitive and/or behavioral involvement and C9orf72 mutation.

Materials and Methods {#s1}
=====================

Participants
------------

Sixty-six non-demented patients diagnosed with probable or definite ALS, according to El Escorial revised criteria ([@B7]) and 28 healthy control (HC) volunteers were included in the study. Exclusion criteria were comorbid frontotemporal dementia ([@B28]), Alzheimer's disease (NIA-AA), evidence of another neurologic condition affecting cognition (e.g., head trauma, hydrocephalus, and vascular disease), drug or alcohol abuse, mental retardation, primary psychiatric disorders, and other severe medical conditions. The review board of the Fondazione IRCCS Istituto Neurologico Carlo Besta of Milan approved the study. Each subject was enrolled after giving written informed consent.

ALS Subgroups
-------------

Patients were assigned to subgroups on the basis of the genetic screening for C9orf72 mutations and on the basis of the presence of cognitive (ALSci) and/or behavioral (ALSbi) impairment as defined by recent guidelines ([@B34]). Accordingly, a cognitive screening protocol was administer to all participants ([@B13]; [Table 1](#T1){ref-type="table"}). Our cohort was composed of 13 patients with a pathological C9orf72 expansion (C9+ALS) and 53 non-affected C9orf72 patients (C9-ALS). Among C9-ALS patients, 31 patients had normal cognitive profile (C9-ALScn) and 22 had ALSci and/or ALSbi (C9-ALSimp).

###### 

Demographic, clinical and neuropsychological data (mean ± standard deviation).

                                C9-ALScn *N* = 31   C9-ALSimp *N* = 22   C9+ALS *N* = 13   HC *N* = 28    Group comparisons
  ----------------------------- ------------------- -------------------- ----------------- -------------- -------------------------------------------------
  **Demographic data**                                                                                    
  Age (yrs.)                    58.22 ± 9.4         60.81 ± 11.7         57.76 ± 8.5       57.28 ± 10.1   n.s.
  Education (yrs.)              11.29 ± 3.8         11.45 ± 4.1          8.53 ± 3.2        11.82 ± 3.7    C9+ALS \< HC^∗^
  Male / Female                 16 / 15             11 / 11              4 / 9             12 / 16        n.s.
  Handedness (EHI)              21.60 ± 3.9         20.00 ± 6.13         21.33 ± 6.1       22.04 ± 1.8    n.s.
  **Clinical data**                                                                                       
  ALSFRS-R                      39.22 ± 5.6         37.95 ± 7.6          39.00 ± 6.09      --             n.s.
  Disease duration (mos.)       16.81 ± 12.0        18.77 ± 13.5         13.15 ± 7.3       --             n.s.
  Progression rate index        0.65 ± 0.4          0.63 ± 0.4           0.91 ± 0.8        --             n.s.
  Bulbar onset (yes / no)       3 / 28              7 / 15               3 / 10            --             n.s.
  **Neuropsychological data**                                                                             
  ALSci / ALSbi / ALScbi        0 / 0 / 0           17 / 1 / 4           8 / 2 / 0         --             C9+ALS \> C9--ALS^∗^
  Phonemic fluency index        4.83 ± 1.9          6.90 ± 4.16          8.25 ± 7.9        4.17 ± 2.0     C9-ALSimp \> HC^∗^
  Object naming (% correct)     95.72 ± 3.8         86.34 ± 10.2         89.09 ± 13.1      94.76 ± 4.9    C9-ALSimp \< HC^∗∗∗^ C9-ALSimp \< C9-ALScn^∗∗∗^
  Emotion attribution (SET)     4.89 ± 1.2          3.38 ± 1.56          3.36 ± 2.0        4.89 ± 1.1     C9-ALSimp \< HC^∗∗^ C9-ALSimp \< C9-ALScn^∗∗^
  Stroop effect                 19.02 ± 8.1         31.31 ± 24.1         25.08 ± 9.3       20.25 ± 7.9    C9-ALSimp \< C9-ALScn^∗^
  Delayed recall RAVLT          10.00 ± 2.5         7.62 ± 2.7           7.72 ± 3.28       10.36 ± 2.6    C9-ALSimp \< HC^∗∗^ C9-ALSimp \< C9-ALScn^∗∗^
  FBI tot                       1.96 ± 2.5          4.00 ± 6.7           2.03 ± 3.4        --             n.s.
                                                                                                          

ALSbi, ALS patients fulfilling Strong criteria for behavioral impairment; ALSci, ALS patients fulfilling Strong criteria for cognitive impairment; ALScbi, ALS patients fulfilling criteria for ALSci and ALSbi; ALSFRS-R, Revised ALS Functional Rating Scale; FBI, Frontal Behavioral Inventory; RAVLT, Rey Auditory Verbal Learning Test; SET, Story-based Empathy Task; and ns, not significant difference (

p

\> 0.05).

∗∗∗

p

\< 0.001;

∗∗

p

\< 0.005;

∗

p

\< 0.05.

Magnetic Resonance Imaging
--------------------------

All patients and healthy participants underwent a magnetic resonance imaging (MRI) session within a week of neuropsychological assessment, on a Philips Achieva 3.0 T. The MRI protocol included a 3D T1-weighted sequence (FFE, 240 sagittal slices, TR = 9.9 ms, TE = 4.6 ms, matrix 240 × 240, voxel size = 1 × 1 × 1 mm3, and flip angle = 8). In order to have a quantitative evaluation of cerebellum lobules representing the current state of the art, we used the CERES automated cerebellum parcellation algorithm ([@B29]). With this tool, the MRI images are denoised, corrected for inhomogeneity, rigid-body registered to Montreal Neurological Institute (MNI) template, cropped around the cerebellum area, and normalized to the MNI cropped cerebellum atlas. An automatic multi-atlas patch-based segmentation was then applied to obtain cerebellar cortical thickness (CT) and volume (CV), expressed in percentage of total intracranial volume, for each lobule ([@B24]).

### Cerebellar Cluster Identification

CT and CV measures over twelve cerebellar lobules were obtained. Principal Component Analysis (PCA) was then applied as an unbiased method to reduce the number of variables for subsequent between-group and correlation analyses. PCA with oblimin rotation was used to identify the clustering pattern (of highly correlated variables) of cerebellar CT and CV measures of all subjects. For this purpose, for each CT and CV measure, *z*-scores were calculated by subtracting the mean CT and CV of HC subjects from the patient's CT and CV, and then dividing the difference by the HC group standard deviation. All variables were normally distributed and had Kaiser-Meyer-Olkin (KMO) values higher than 0.5. Clusters with eigenvalues over the Kaiser criterion of one were retained. Cluster scores were calculated with the Anderson-Rubin method and used for between group and correlation analyses ([@B16]).

Statistics
----------

The Kolmogorov--Smirnov test was used to test the normality of the distribution of demographic, clinical, neuropsychological and neuroimaging data. Fisher Exact test, Kruskal--Wallis and Mann--Whitney *U* tests were used to test between group differences (i.e., C9-ALSimp, C9-ALScn, C9+ALS, and HC). The variability of cerebellar cluster loadings of groups was analyzed by ANCOVA, with age as covariates. Simple contrasts were then used to test specific group comparisons. Partial correlation analyses (correcting for age and education) were used to explore the relationship of cerebellar cluster scores with neuropsychological and clinical profiles in all patients as a whole group. Significant correlations were then bias corrected and accelerated bootstrap 95% confidence intervals (CIs) were computed with 1000 bootstrap equally sized samples obtained by randomly resampling replacement from the original data. Partial correlations with *p* \< 0.05 and CIs not crossing "0" were reported. IBM SPSS Statistics (version 21) was used to perform analyses.

Results
=======

Clinical, Demographic and Neuropsychological Data
-------------------------------------------------

Descriptive statistics are summarized in [Table 1](#T1){ref-type="table"}. C9-ALScn, C9-ALSimp, C9+ALS, and HC groups did not differ in to age, handedness, gender, but education (*H* = 9.019, *p* = 0.029). The C9+ALS group had a slightly lower education level than the HC group (*U* = 93.0, *p* = 0.012). Disease duration, functional disability assessed with the ALSFRS-R, progression and type of onset were similar across ALS subgroups. HC and C9-ALScn groups had similar neuropsychological performances. The occurrence of cognitive and/or behavioral impairment is higher for C9+ALS patients than C9-ALS patients (77% vs. 41%; *p* = 0.031). The C9-ALSimp group compared with HC and C9-ALScn groups had lower performances in all cognitive domains ([Table 1](#T1){ref-type="table"}).

Cerebellar Clustering Patterns
------------------------------

**CTz.** The KMO measure tested the sample adequacy of 12 cerebellar lobular CTz values for PCA (KMO = 0.708). The rotation converged on 23 iterations. Four clusters had eigenvalues over Kaiser criterion of one and in combination explained 78.41% of the variance ([Table 2](#T2){ref-type="table"}). Cluster 1 included CTz values of lobule VIIIA, VIIIB, and IX; Cluster 2 included CTz values of Crus II and VIIB, Cluster 3 loadings were CTz values of lobule IV, V, VI, and Crus I; cluster 4 included lobule I&II and III and X.

###### 

Pattern matrix of PCA results for cerebellar lobar values of Cortical Thickness (CT) of 94 subjects \[66 patients with ALS and 24 healthy controls (HCs)\].

                                  Rotated cluster loadings                            
  ------------------- ----------- -------------------------- ------------ ----------- -------
  CTz Lobule IX       **0.882**   0.100                      -0.165       0.181       0.752
  CTz Lobule VIIIB    **0.854**   0.210                      -0.246       0.398       0.746
  CTz Lobule VIIIA    **0.704**   0.672                      -0.120       0.220       0.725
  CTz Lobule VIIB     0.255       **0.894**                  0.004        -0.049      0.595
  CTz Lobule CRUSII   0.053       **0.840**                  -0.472       0.003       0.645
  CTz Lobule VI       0.113       0.112                      **-0.858**   0.144       0.822
  CTz Lobule CRUS I   0.050       0.404                      **-0.830**   0.048       0.693
  CTz Lobule V        0.509       -0.160                     **-0.767**   0.373       0.763
  CTz Lobule IV       0.472       -0.184                     **-0.745**   0.490       0.728
  CTz Lobule I&II     0.221       -0.083                     -0.114       **0.882**   0.685
  CTz Lobule III      0.130       -0.195                     -0.213       **0.861**   0.612
  CTz Lobule X        0.247       0.138                      -0.110       **0.454**   0.700
  Eigenvalues         3.929       2.295                      1.757        1.122       
  \% of variance      32.74       19.13                      14.64        9.35        
                                                                                      

The loading values in bold indicate the elements that contribute the greatest variability to PCA clusters. ALScn, ALS patients with a cognitive and behavioral normal profile; ALSimp, ALS patients fulfilling Strong criteria for behavioral and/or cognitive impairment; C9+ALS, ALS patients with C9orf72 repeat expansions; and HC, Healthy Controls.

**CVz.** The KMO measure tested the sample adequacy of 12 cerebellar lobular CV for PCA (KMO = 0.671). The rotation converged on 10 iterations. Four clusters had eigenvalues over Kaiser criterion of one and in combination explained 62.13% of the variance ([Table 3](#T3){ref-type="table"}). Cluster 1 included CVz of lobule VIIIB, IX, and X; Cluster 2 included CVz of anterior lobules (I&II, III, IV, and V); Cluster 3 loadings were CVz values of CrusII, VIIB and VIIIA; cluster 4 included CVz of lobule VI and Crus I.

###### 

Pattern matrix of PCA results for cerebellar lobar values of Cortical Volumes (CV) of 94 subjects (66 patients with ALS and 24 HCs).

                      Rotated cluster loadings                                       
  ------------------- -------------------------- ----------- ----------- ----------- -------
  CVz Lobule IX       **0.826**                  -0.079      0.283       0.155       0.661
  CVz Lobule VIIIB    **0.727**                  0.391       0.153       0.108       0.690
  CVz Lobule X        **0.651**                  -0.054      0.324       0.494       0.779
  CVz Lobule III      -0.035                     **0.788**   0.264       0.040       0.655
  CVz Lobule V        0.201                      **0.684**   0.126       0.506       0.685
  CVz Lobule I&II     0.057                      **0.602**   0.002       -0.014      0.528
  CVz Lobule IV       0.487                      **0.498**   0.119       0.364       0.702
  CVz Lobule CRUSII   0.298                      0.066       **0.831**   -0.016      0.609
  CVz Lobule VIIB     -0.092                     0.130       **0.773**   0.284       0.668
  CVz Lobule VIIIA    0.351                      0.119       **0.692**   0.115       0.702
  CVz Lobule VI       0.006                      0.255       0.174       **0.809**   0.601
  CVz Lobule CRUS I   0.339                      -0.095      0.070       **0.697**   0.677
  Eigenvalues         3.226                      1.653       1.408       1.166       
  \% of variance      26.88                      13.77       11.73       9.71        
                                                                                     

The loading values in bold indicate the elements that contribute the greatest variability to PCA clusters. ALScn, ALS patients with a cognitive and behavioral normal profile; ALSimp, ALS patients fulfilling Strong criteria for behavioral and/or cognitive impairment; C9+ALS, ALS patients with C9orf72 repeat expansions; and HC, Healthy Controls.

We did not find group differences in cluster scores of CTz and CVz measures ([Table 4](#T4){ref-type="table"}). Correlation analyses revealed that only CVz scores of the second and third cluster were related to functional disability measured with the ALSFRS-R in all patients (*r* = 0.283, *p* = 0.024, CIs: 0.043--0.468; *r* = 0.281, *p* = 0.026, CIs: 0.053--0.467). Cluster 2 CVz scores were also related to the progression rate (*r* = -0.248, *p* = 0.050, CIs: -0.087 -- -0.403). Cluster 4 CVz scores were inversely related to the phonemic fluency index (*r* = -0.335, *p* = 0.010, CIs: -0.157 -- -0.535).

###### 

Clustering pattern of cerebellar lobules (mean cluster score ± standard deviation).

                                             ALScn *N* = 31   ALSimp *N* = 22   C9+ALS *N* = 13   HC *N* = 28     Group comparisons
  ------------------------------------------ ---------------- ----------------- ----------------- --------------- -------------------
  **Cortical thickness -- cluster scores**                                                                        
  1\. Lobule VIIIA, VIIIB, IX                -0.278 ± 0.96    0.362 ± 0.75      -0.253 ± 1.27     0.141 ± 0.99    n.s.
  2\. Lobule Crus II, VIIB                   -0.004 ± 1.14    0.076 ± 0.82      -0.531 ± 1.16     0.191 ± 0.83    n.s.
  3\. Lobule IV, V, VI, Crus I               -0.272 ± 0.89    -0.063 ± 0.80     0.463 ± 1.43      0.136 ± 0.95    n.s.
  4\. Lobule I&II, III, X                    -0.122 ± 1.07    0.353 ± 0.88      0.125 ± 0.99      -0.200 ± 0.96   n.s.
  **Cortical volumes -- cluster scores**                                                                          
  1\. Lobule VIIIB, IX, X                    0.038 ± 0.86     -0.191 ± 0.94     0.263 ± 1.44      -0.014 ± 0.95   n.s.
  2\. Lobule I&II, III, IV, V                0.064 ± 0.97     -0.086 ± 1.29     -0.014 ± 1.11     0.003 ± 0.72    n.s.
  3\. Lobule Crus II, VIIB, VIIIA            -0.042 ± 0.96    -0.323 ± 1.03     0.004 ± 0.99      0.299 ± 0.98    n.s.
  4\. Lobule VI, Crus I                      0.201 ± 0.92     -0.306 ± 0.80     0.006 ± 0.87      0.014 ± 1.23    n.s.
                                                                                                                  

n.s., not significant differences (

p

\> 0.05).

Discussion
==========

We tested the relationship between cerebellar degeneration, cognitive syndromes and C9orf72 mutation in ALS patients. The notion that cerebellum contributes to non-motor disorders, such as impairments in language, attention and social cognition is well recognized ([@B8]). Consistently, we performed a quantitative *in vivo* assessment of cerebellar lobular CT and CV in a large sample of non-demented ALS patients stratified on the basis of cognitive and/or behavioral impairment and C9orf72 repeat expansion. To this aim, we used an unbiased reduction method, the PCA, which allows projecting data into a lower-dimensional space thus reducing the type I error and identifying clusters of highly correlated variables with each other ([@B16]).

We identified 4 clusters of regional cerebellar CT and demonstrated their scores were similar across ALS subgroups and HC individuals. Moreover, the lack of significant correlations between cerebellar CT values, neuropsychological performances and clinical features in patients suggests that the cerebellar cortical thinning has a poor sensibility to detect cognitive impairment in ALS. Cognitive and neuropsychiatric features of ALS seem to be associated instead with thinning in frontotemporal and insular cortex ([@B32]; [@B1]; [@B14],[@B15]).

By means of lobar CV measures, we identified four clustering patterns. The clustering of the cerebellum respected lobular anatomical boundaries and functional organization. Cluster 1 included posterior regions (VIIIB-IX, X), cluster 2 the sensory-motor anterior regions (I-V), cluster 3 (CrusII-VIIIA), and 4 (VI-CrusI) included mainly cognitive posterior lobules. Contrary to our expectation, no significant group differences in cluster scores were found, but, as explorative analysis, a weak but significant correlation between CV measures of the fourth cluster and phonemic fluency indexes of ALS patients. Verbal fluency is a widely recognized marker of dysexecutive impairment in ALS ([@B34]). Specifically, poor verbal fluency was related to reduced CV of lobule VI and CrusI. This is consistent with previous studies documenting that lobules VI and Crus I are involved in executive functions, such as working memory, planning, organizing, and strategy formation ([@B33]). According to a meta-analysis of voxel-based morphometry in cerebellum ([@B20]), the largest cluster of gray matter reduction in ALS spanned parts of the vermis and neighboring regions in left lobule VI, Crus I, and Crus II. This suggests that cerebellar involvement in ALS may be related to progressive cognitive impairment. However, as in other studies ([@B31]), we did not find differences in cerebellar volume within ALS cognitive subgroups, albeit specific patterns of cerebellum atrophy in ALS-FTD patients have been previously reported ([@B35]; [@B25]; [@B11],[@B12]). We could not exclude that discrepancies between our findings and those reported by others are attributed to differences in sample sizes and patients' clinical features, as well as different methodological (e.g., Surface-Based Analysis vs. Voxel-Based Morphometry) and statistical approach and whether the whole cerebellum or focal cerebellar regions were addressed.

We also found that severe motor disability and high rate of disease progression were slightly related to CV reduction of the sensory-motor cerebellar lobules. This is consistent with the evidence of gradually progressive cerebellar gray matter degeneration throughout disease progression in ALS ([@B6]). A recent study showed reduced gray matter volume (lobule IV and V) in ALS patients with no cognitive defect and posterior (VIII) cerebellar involvement in ALS patients with cognitive impairment ([@B11]). This is in line with our correlation analyses, confirming that specific patterns of subregional involvement are differently associated with cognitive and motor impairment in ALS ([@B35]).

Unexpectedly, our investigation of the cerebellar subregions did not revealed atrophy clusters specific for C9+ALS patients, which is consistent with recent findings ([@B17]; [@B31]) but not with others ([@B38]; [@B2]). Since cerebellar involvement in C9orf72 carriers have been found among FTD-ALS spectrum ([@B3]; [@B21]; [@B17]), it is conceivable that it may reflect a signature of ALS dementia other than a signature of the C9orf72 hexanucleotide repeat ([@B3]). Further studies deserve larger C9+ALS samples stratified on the basis of the degree of cognitive impairment to address this issue.

The strength of the presented study was the tentative to systematically explore the cognitive contributions of cerebellar atrophy in selected cohorts of patients with ALS. Our data show that cerebellar degeneration is not specific for non-demented patients with ALS and cognitive syndromes or C9orf72 mutations. However, the relatively small number of mutation carriers and the lack of ALS-FTD patients included limit the strength for firm conclusion. Indeed, we could not exclude that overall disease progression both in terms of progressive physical disability and progressive cognitive impairment might be related to cerebellar involvement, in line with its topographic organization.

Data Availability
=================

The datasets generated for this study are available on request to the corresponding author.

Ethics Statement
================

The review board of the Fondazione IRCCS Istituto Neurologico Carlo Besta of Milan approved the study. Each subject was enrolled after giving written informed consent.

Author Contributions
====================

MC, EDB, AN, CP, CG, and SF collected the data. AN, CP, GD, MB, and SF acquired and the analyzed neuroimaging data. MC, SF, and SC designed the study. MC and LP performed the statistical analyses. MC, EDB, SC, MB, GL, and SF gave important intellectual content in data interpretation. MC, EDB, LP, and AN wrote a draft of the manuscript. MC, SC, GL, and SF revised the final version of the manuscript for intellectual content. MC, EDB, AN, CP, GD, LP, CG, VP, SC, MB, GL, and SF read and approved the final version.

Conflict of Interest Statement
==============================

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

**Funding.** This work has been supported by Fondazione Regionale per la Ricerca Biomedica (Regione Lombardia), project nr. 2015-0023.

We thank neurologists of the Fondazione IRCCS Istituto Neurologico Carlo Besta of Milan, Patrizia Dacci, Daniele Cazzato, Susanna Usai, Ettore Salsano, and Davide Pareyson for referring some patients; Valentina E.C. Gessa for the neuropsychological assessment of some patients.

[^1]: Edited by: Foteini Christidi, National and Kapodistrian University of Athens, Greece

[^2]: Reviewed by: Michael Hornberger, University of East Anglia, United Kingdom; Mattia Siciliano, Second University of Naples, Italy

[^3]: This article was submitted to Neurodegeneration, a section of the journal Frontiers in Neuroscience
